Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group
Related Experiment Video
Updated: Oct 17, 2026

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
Published on: September 11, 2019
Y Allory1, F Charlotte, Y Benhamou
1Service d'Anatomie et de Cytologie Pathologiques, Groupe Hospitalier Pitié-Salpétrière, Paris, France.
Insights
Human immunodeficiency virus (HIV) accelerates hepatitis C virus (HCV) liver disease progression. HIV-positive patients with low CD4 counts showed significantly higher rates of cirrhosis compared to others.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) share transmission routes, leading to frequent co-infection.
- Previous research indicated HIV may worsen chronic hepatitis C, accelerating cirrhosis, but lacked control for key fibrosis factors.
Purpose of the Study:
- To investigate the impact of HIV on the progression of liver fibrosis in chronic hepatitis C patients.
- To analyze liver biopsy data, controlling for risk factors like alcohol, sexual transmission, age, and duration of HCV infection.
Main Methods:
- Comparative analysis of liver biopsy specimens from 58 HIV/HCV co-infected patients and 58 HCV-monoinfected patients.
- Patients were matched based on known risk factors for liver fibrosis progression.
- Liver fibrosis and activity were assessed using the METAVIR scoring system.
Main Results:
- HCV patients with HIV exhibited higher METAVIR activity scores compared to HIV-negative patients.
- Cirrhosis was significantly more prevalent in HIV-positive patients with CD4 counts ≤ 200 cells/µL (45%) versus HIV-negative patients (10%).
- Within the HIV-positive group, those with CD4 counts ≤ 200 cells/µL had higher cirrhosis rates (45%) than those with CD4 > 200 cells/µL (17%).
Conclusions:
- HIV status significantly influences the progression of liver disease in patients with chronic hepatitis C.
- Lower CD4+ T-cell counts in HIV-positive individuals correlate with increased rates of cirrhosis.
- Enhanced HCV replication or altered immune responses during HIV infection may drive accelerated liver fibrosis.
Abstract:
Hepatitis C virus (HCV) is frequently encountered in human immunodeficiency virus (HIV)-infected patients because of common routes of transmission. Previous studies suggested that HIV infection impaired the natural course of chronic hepatitis C, with a more rapid progression to cirrhosis. However, these studies did not assess the HIV infection impact on chronic hepatitis C by taking into account the risk factors for liver fibrosis progression: alcohol, sex, age at the contamination, and duration of HCV infection. We studied liver biopsy specimens of 2 groups of 58 patients that were infected by both HCV and HIV or by HCV alone. The 2 groups were matched according those risk factors, and liver biopsy responses were evaluated with the METAVIR items. The METAVIR activity was higher in HIV-positive than HIV-negative patients. Cirrhosis was more frequent: (1) in HIV-positive patients with CD4 < or = 200 cells/microL (45%) than in HIV-negative patients (10%) (P = .003), (2) in HIV-positive patients with CD4 < or = 200 cells/microL (45%) than in HIV-positive patients with CD4 > 200 cells/microL (17%) (P = .04). These differences, which were linked to HIV status, might be related to the enhanced HCV replication during HIV infection or other immune mechanisms that need further studies.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
